Ling Qin-Nelson
Cardiovascular Disease · Fort Wayne, INNPI 1841586526
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 46.3% of the total. 2025 is the largest year on record at $5,897, 2.2 times the $2,690 reported in 2019.
Across 208 payments — averaging $70.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abiomed$2K
- Philips North America LLC$2K
- Boston Scientific$1K
- Angiodynamics, Inc.$592
- AstraZeneca$274
- plus $2K from 25 others
What the payments were for
- Travel & lodging$6,74446%
- Food & beverage$7,90554%
- Education$1121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 78 | $6,837 |
| Abiomed | 20 | $2,095 |
| Philips North America LLC | 21 | $1,588 |
| Boston Scientific | 9 | $1,419 |
| Angiodynamics, Inc. | 12 | $592 |
| AstraZeneca | 4 | $274 |
| Asahi Intecc USA, Inc. | 1 | $267 |
| Johnson & Johnson | 7 | $205 |
| Abbott | 1 | $164 |
| Heartflow, Inc. | 1 | $150 |
| Merck | 6 | $146 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $144 |
| Biotronik Inc. | 2 | $114 |
| Reflow Medical Inc | 3 | $113 |
| Actelion Pharmaceuticals US, Inc. | 7 | $94 |
| Penumbra, Inc. | 1 | $82 |
| Bard Peripheral Vascular, Inc. | 1 | $70 |
| Novartis | 3 | $48 |
| Pfizer | 3 | $45 |
| Inari Medical, Inc. | 1 | $42 |
| Amarin Pharma, Inc. | 3 | $41 |
| Stryker | 1 | $41 |
| Grifols USA, LLC | 3 | $35 |
| Pulmonx Corporation | 1 | $32 |
| Amgen | 2 | $27 |
| Novo Nordisk | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Bayer | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Lantheus Medical Imaging, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,899
- GENERAL - THERAPIES$1,163
- Impella$1,071
- Azure$770
- TurboHawk$762
- Advisa$728
- IGT D Peripheral$535
- Abre$434
- VenaSeal$376
- (6554) Periph Vasc Undiv$375
- Asahi Coronary Wires$267
- AMPLATZER TALISMAN$164
- FFRct$150
- Auryon Laser System 100-120 Vac$145
- FARXIGA$125
- XARELTO$117
How this compares
$14,760 in reported general payments places this provider in the 80th percentile of 408 cardiovascular disease providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 13 | $211 |
| ClopidogrelClopidogrel Bisulfate | 25 | $200 |
| Metoprolol Succinate | 14 | $168 |
| Atorvastatin Calcium | 17 | $127 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Fort Wayne
- Michael MirroFort Wayne$57K
- Louis LopezFort Wayne$36K
- Issa KutkutFort Wayne$18K
- John MillerIndianapolis$354K
- David KovacichIndianapolis$327K
- Wai LeeElkhart$321K
- Anas SafadiHobart$295K
- Lawrence RinkBloomington$280K
- Vijay RaoIndianapolis$247K
- Steven SteinhublLafayette$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.